Evaluation of an Immunomodulator Drug as a Radioprotectant on Human Peripheral Blood Lymphocytes In Vitro

Journal Title: Middle East Journal of Cancer - Year 2018, Vol 9, Issue 1

Abstract

Background: IMOD™, a selenium enriched extract of the plants Tanacetum vulgare, Urtica dioica, and Rosa canina, has an excellent effect on oxidative stress. In this study, we investigated the radioprotective effects of this immunomodulatory drug on human peripheral blood lymphocytes. Methods: Peripheral blood samples obtained from venipuncture of the brachial vein were treated with IMOD™ (5, 10, 15, 20 μl) for 30 min and Cobalt 60 γ-rays (0.25, 0.5, 1, 2 Gy) as the test groups and cultured with the control. We used the micronuclei assay, cell death detection, and cell toxicity assay to analyze the treatment effects. Results: The frequency of micronuclei were 1.66 (0 Gy), 5.33 (0.25 Gy), 9.67 (0.5 Gy), 17.67 (1 Gy), and 23.67 (2 Gy) in the irradiated lymphocytes (P<0.001). The percentage of micronuclei frequency reduced to 20%, 26.83%, 37.68%, 16%, and 20.47% with IMOD™. Apoptosis and necrosis decreased significantly in the IMOD™ treated groups (P<0.05). Conclusion: IMOD™ may protect these cells against ionizing radiation.

Authors and Affiliations

Zahra Sattarpour, Behzad Baradaran, Alireza Farajollahi, Mohammad Asghari Jafarabadi, Vahid Khazeh, Jalil Pirayesh Islamian

Keywords

Related Articles

Wilms’ Tumor: Histopathological Variants and the Outcomes of 31 Cases at a Tertiary Care Center in Northern India

Background: Wilms’ tumor is the most common malignant renal tumor in the pediatric age group. This tumor is classically managed by multimodal treatment which involves surgery, radiotherapy and chemotherapy. While there i...

Valuable Modern Strategy (ATR-IR) Spectroscopy Technique to Distinguish Between Normal and Lung Cancer Tissue

Background: Diagnosis of lung cancer is often delayed because most of the patients are asymptomatic during the primary cancer stages. Infrared spectroscopy is an improved technique compared with the others for identifyin...

Global Inequalities in Cervical Cancer Incidence and Mortality

Objective: Cervical cancer (CC) is the third most common cancer in women after breast and colorectal cancers and is one of the leading causes of cancer death among women in the world. The aim this study is associations o...

Salivary Parameters as Predictive Markers for Radiation-induced Treatment Response in Head and Neck Cancers: An Investigational Study

Background: This study evaluates the predictive significance of salivary amylase, glutathione, lipid peroxides, and lactate dehydrogenase in the treatment of head and neck cancer patients who undergo curative radiotherap...

Extranodal Non-Hodgkin Lymphomas: The Impact of Different Variables on the Disease

Background: Extranodal non-Hodgkin lymphoma (ENL) occurs in 25-40% of non-Hodgkin lymphoma (NHL) patients. The objective of this study is to analyze the incidence, anatomical distribution, histopathological subtypes, pro...

Download PDF file
  • EP ID EP302559
  • DOI -
  • Views 105
  • Downloads 0

How To Cite

Zahra Sattarpour, Behzad Baradaran, Alireza Farajollahi, Mohammad Asghari Jafarabadi, Vahid Khazeh, Jalil Pirayesh Islamian (2018). Evaluation of an Immunomodulator Drug as a Radioprotectant on Human Peripheral Blood Lymphocytes In Vitro. Middle East Journal of Cancer, 9(1), 35-40. https://europub.co.uk./articles/-A-302559